AFP and hepatocellular carcinoma: HCC detection has relied largely on screening high risk groups with serological markers such as alpha-fetoprotein (AFP), followed by imaging of the liver by ultrasound (US) 4, however current professional guidelines have largely abandoned AFP on its own because of its low sensitivity (40-60%) and because many HCCs are AFP-negative 4, 5.